Inhibition of Ca2+ influx by surfactant in NR8383 alveolar macrophages

Inflammation Research

Volumn 57, Issue 10, 2008, Pages 489-496

  Castro, R ^a   Sun, X H ^a   Liu, X B ^a   Martinez, J R ^a   Zhang, G H ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Alveolar macrophage; Calcium; PKC; Surfactant; Zymosan

Indexed keywords

BERACTANT; CALFACTANT; CERAMIDE; DIOCTANOIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; FURA 2; INTERLEUKIN 1BETA; LUNG SURFACTANT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN; 1 (2 (3 (4 METHOXYPHENYL)PROPOXY) 4 METHOXYPHENYLETHYL) 1H IMIDAZOLE; 1-(2-(3-(4-METHOXYPHENYL)PROPOXY)-4-METHOXYPHENYLETHYL)-1H-IMIDAZOLE; BIOLOGICAL PRODUCT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; NONHUMAN; RAT; ANIMAL; CELL LINE; CYTOLOGY; METABOLISM; SECRETION;

ANIMALS; BIOLOGICAL PRODUCTS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL LINE; CYTOKINES; IMIDAZOLES; MACROPHAGES, ALVEOLAR; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; PULMONARY SURFACTANTS; RATS; ZYMOSAN;

EID: 58149216259     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-6214-y     Document Type: Article

References (41)

1. Ahuja A, Oh N, Chao W, Spragg RG, Smith RM. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant. Am J Resp Cell Mol Biol 1996; 14: 496-503.
2. Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol 1999; 276: L186-L196.
3. Hayakawa H, Myrvik QN, St.Clair RW. Pulmonary surfactant inhibits priming of rabbit alveolar macrophage. Evidence that surfactant suppresses the oxidative burst of alveolar macrophage in infant rabbits. Am Rev Resp Dis 1989; 140: 1390-7.
4. Finck CM, Hodell MG, Marx WH, Paskanik AM, McGraw DJ, Lutz CJ, et al. Endotoxin-stimulated alveolar macrophage recruitment of neutrophils and modulation with exogenous surfactant. Crit Care Med 1998; 26: 1414-8.
5. Allen JN, Moore SA, Pope-Harman AL, Marsh CB, Wewers MD. Immunosuppressive properties of surfactant and plasma on alveolar macrophages. J Lab Clin Med 1995; 125: 356-69.
6. Thomassen MJ, Antal JM, Connors MJ, Meeker DP, Wiedemann HP. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am J Resp Cell Mol Biol 1994; 10: 399-404.
7. Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Resp Cell Mol Biol 1992; 7: 257-60.
8. Kremlev SG, Umstead TM, Phelps DS. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am J Physiol 1997; 272: L996-1004.
9. Kalina M, Blau H, Riklis S, Hoffman V. Modulation of nitric oxide production by lung surfactant in alveolar macrophages. In: Keisari Y, Ofek I, editors. The Biology and Pathology of Innate Immunity Mechanisms. Kluwer Academic/Plenum, 2000:37-48.
10. Thomassen MJ, Antal JM, Divis LT, Wiedemann HP. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf. Clin Immunol & Immunopath 1995; 77: 201-5.
11. Miles PR, Bowman L, Rengasamy A, Huffman L. Constitutive nitric oxide production by rat alveolar macrophages. Am J Physiol 1998; 274: L360-L368.
12. Tanaka F, Suga M, Nishikawa H, Muranaka H, Ando M. Effects of pulmonary surfactant on macrophage migration: suppression of chemokinesis by surfactant phospholipid and enhancement of chemotaxis by surfactant protein. Respirology 1997; 2: 119-26.
13. Jones BG, Dickinson PA, Gumbleton M, Kellaway IW. Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383. J Pharm & Pharmacol 2002; 54: 1065-72.
14. Monick MM, Hunninghake GW. Second Messenger Pathways in Pulmonary Host Defense. Ann Rev Physiol 2003; 65: 643-67.
15. Lei MG, Morrison DC. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol 1988; 141: 996-1005.
16. Hotchkiss RS, Bowling WM, Karl IE, Osborne DF, Flye MW. Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages. Shock 1997; 8: 170-8.
17. Park Y, Jun C, Kang H, Kim H, Kim H, Chung H. Role of intracellular calcium as a priming signal for the induction of nitric oxide synthesis in murine peritoneal macrophages. Immunology 1996; 87: 296-302.
18. Chacon-Cruz E, Buescher ES, Oelberg DG. Surfactant Modulates Calcium Response of Neutrophils to Physiologic Stimulation via Cell Membrane Depolarization. Pediatr Res 2000; 47: 405-13.
19. Boston ME, Frech GC, Chacon-Cruz E, Buescher ES, Oelberg DG. Surfactant releases internal calcium stores in neutrophils by G protein-activated pathway. Exp Biol Med 2004; 229: 99-107.
20. Helmke RJ, German VF, Mangos JM. A Continuous Alveolar Macrophage Cell Line: Comparisons with Freshly Isolated Derived Alveolar Macrophages. In Vitro Cell & Dev Biol 1989; 25: 44-8.
21. Michalek M, Melican D, Brunke-Reese D, Langevin M, Lemerise K, Galbraith, et al. Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J Leukoc Biol 1998; 64: 337-44.
22. Lane KB, Egan B, Vick S, Abdolrasulnia R, Shepherd VL. Characterization of a rat alveolar macrophage cell line that expresses a functional mannose receptor. J Leukoc Biol 1998; 64: 345-50.
23. Lin T-J, Hirji N, Stenton GR, Gilchrist M, Grill BJ, Schreiber AD, et al. Activation of macrophage CD8: Pharmacological Studies of TNF and IL-1β production. J Immunol 2000; 164: 1783-92.
24. Mörk AC, Helmke RJ, Martinez JR, Michalek MT, Patchen ML, Zhang GH. Effects of Particulate and Soluble (1-3)-Beta-glucan-on Ca2+ influx in NR8383 Alveolar Macrophage. Immunopharmacology 1998; 40: 77-89.
25. 2+ in Cultured Rat Alveolar Macrophages (NR8383). J Leukoc Biol 1997; 62: 341-8.
26. 2+ Influx by Protein Kinase C in NR8383 Alveolar Macrophages. J Cell Biochem 2000; 78: 131-40.
27. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
28. Sun X, Martinez JR, Zhang GH. Inhibition of Ca2+ influx by pentoxifylline in NR8383 alveolar macrophages. Immunopharmacology 1999; 43: 47-58.
29. Raychaudhuri B, Abraham S, Bonfield TL, Malur A, Deb A, DiDonato JA, Kavuru MS, Thomassen MJ. Surfactant Blocks Lipopolysaccharide Signaling by Inhibiting both Mitogen-Activated Protein and I{kappa}B Kinases in Human Alveolar Macrophages. Am J Respir Cell Mol Biol 2004; 30: 228-32.
30. Qiu ZH, Leslie CC. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J Biol Chem 1994; 269: 19480-7.
31. 2+ influx in human neutrophils occurs via store-operated mechanisms. J Leukoc Biol 2001; 69: 63-8.
32. Harada RN, Repine JE. Pulmonary host defense mechanisms. Chest 1985; 87: 247-52.
33. Suresh GK, Soll RF. Overview of Surfactant Replacement Trials. J Perinatol 2005; 25, S40-S44.
34. Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998; 64: 25-32.
35. 2+ in human neutrophils? Bioch Biophys Res Commun 1994; 203: 998-1004.
36. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ. Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol 1996; 14: 374-9.
37. Kerecman J, Mustafa SB, Vasquez MM, Dixon PS, Castro R. Immunosuppressive Properties of Surfactant in Alveolar Macrophage NR8383. Inflamm Res 2008; 57: 118-25.
38. Tegtmeyer FK, Gortner L, Ludwig A, Brandt E. In vitro modulation of induced neutrophil activation by different surfactant preparations. Eur Respir J 1996; 9: 752-7.
39. Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatr 1997; 100: 31-8.
40. Nesslein LL, Melton KR, Ikegami M, Na CL, Wert SE, Rice WR, et al. Partial SP-B deficiency perturbs lung function and causes air space abnormalities. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1154-L1161.
41. Wiernik A, Curstedt T, Johansson A, Jarstrand C, Robertson B. Morphology and function of blood monocytes after incubation with lung surfactant. Eur J Respir Dis 1987; 71: 410-8.